Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01037595
Other study ID # 3441
Secondary ID
Status Completed
Phase Phase 0
First received December 22, 2009
Last updated May 12, 2013
Start date September 2010
Est. completion date December 2010

Study information

Verified date May 2013
Source Shiraz University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to see whether turmeric can be effective in treatment of pruritus in hemodialysis patients.


Description:

pruritus is a common in hemodialysis patients and many treatment recommended for it . as turmeric has anti-inflammatory , anti-cytokine and anti-oxidant effect it may effective in treatment of uremic pruritus. thus we compared turmeric with placebo in this study


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2010
Est. primary completion date October 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Hemodialysis for more than 3 months

- More than 18 years old

- Pruritus

Exclusion Criteria:

- Use other treatment for pruritus

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
turmeric
turmeric 500 md tid orally for 8 weeks
placebo
placebo 3 time orally for 8 weeks
turmeric
500 mg tid orally for 8 weeks

Locations

Country Name City State
Iran, Islamic Republic of Shiraz University Hemodialysis Center Shiraz Fars

Sponsors (1)

Lead Sponsor Collaborator
Shiraz University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary improvement in pruritus 6 mo Yes
See also
  Status Clinical Trial Phase
Completed NCT01766882 - Volume,Sodium and Blood Pressure Management in HD N/A
Completed NCT02686398 - Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis Phase 4
Completed NCT01990118 - Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients Phase 4
Recruiting NCT01704313 - A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae N/A
Not yet recruiting NCT06389617 - Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block N/A
Completed NCT01004627 - A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery N/A
Not yet recruiting NCT04376567 - Patient-Centered Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas N/A
Recruiting NCT02895425 - Registry for End Stage Renal Failure N/A
Not yet recruiting NCT02341547 - Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure' N/A
Completed NCT01834755 - Physical and Psychological Profiles Associated With Patient's Preference for ESRD Treatment N/A
Completed NCT01101217 - Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients N/A
Completed NCT01996930 - Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites Phase 3
Not yet recruiting NCT01704339 - Qutenza for Critical Ischaemia in End Stage Renal Failure Phase 4
Recruiting NCT01781156 - Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients N/A
Completed NCT01906840 - Role of Turmeric on Oxidative Modulation in ESRD Patients Phase 1/Phase 2
Not yet recruiting NCT06378931 - Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure